Syndetics omslagsbild
Bild från Syndetics

Merck : pricing Gardasil / Tim Calkins & Megha Vora.

Av: Medverkande: Materialtyp: TextSerie: Utgivningsuppgift: [London] : SAGE, 2016Beskrivning: 1 online resource : illustrations (black and white, and colour)Innehållstyp:
  • text
  • still image
Medietyp:
  • computer
Bärartyp:
  • online resource
ISBN:
  • 9781473970298 (ebook) :
Ämnen: DDK-klassifikation:
  • 658.816 23
Onlineresurser: Allison Watkins, senior director of Merck's Vaccines Division, needed to decide on the pricing of Gardasil, Merck's newest vaccine and one of the company's most important product launches of the year. The outside consulting firm she had hired to recommend a price for Gardasil had suggested a price of {dollar}120 per dose (or {dollar}360 per person, as each person required three doses over six months to achieve adequate immunity). The Gardasil marketing team disagreed about this recommended price; some thought it was clearly too high, whereas others said it was too low. This case examines how Merck resolved this issue.
Inga fysiska exemplar för denna post

Originally Published in: Calkins, T., & Vora, M. (2009). Merck: Pricing Gardasil. 5-308-505. Evanston, IL: Kellogg School of Management, Northwestern University.

Allison Watkins, senior director of Merck's Vaccines Division, needed to decide on the pricing of Gardasil, Merck's newest vaccine and one of the company's most important product launches of the year. The outside consulting firm she had hired to recommend a price for Gardasil had suggested a price of {dollar}120 per dose (or {dollar}360 per person, as each person required three doses over six months to achieve adequate immunity). The Gardasil marketing team disagreed about this recommended price; some thought it was clearly too high, whereas others said it was too low. This case examines how Merck resolved this issue.

Description based on online resource; title from home page (viewed on April 29, 2016).

Licensed e-book